Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks extend record highs, oil rises to highest in more than a yr

Mon, 08th Feb 2021 16:34

* U.S. stocks up early; MSCI all-country world index hits
record

* Brent crosses $60 a barrel

* Hopes of $1.9 trln U.S. stimulus, vaccines, boost
sentiment
(Updates with early U.S. markets activity; changes byline,
dateline, previous LONDON)

By Caroline Valetkevitch

NEW YORK, Feb 8 (Reuters) - A gauge of global stock markets
set another record high on Monday and oil prices rose to their
highest in just over a year as investor optimism grew that U.S.
lawmakers will soon pass a $1.9 trillion COVID-19 aid package.

Investors were keeping an eye on bitcoin as it
rose again, with Elon Musk promising Tesla Inc would
soon take payment for its electric vehicles in the currency and
revealing it had already bought $1.5 billion worth of it.

Benchmark U.S. Treasury yields surged to 11-month highs as
the U.S. fiscal stimulus was seen boosting economic growth and
raising inflation more quickly than expected, and before the
Treasury Department sells new longer-dated debt.

Major U.S. stock indexes hit record highs in early New York
trading, extending a recent streak of gains.

Comments on Sunday by U.S. Treasury Secretary Janet Yellen,
who said that if Congress approves the $1.9 trillion plan, the
country would get back to full employment next year, added to
the optimism.

Congress on Friday approved a budget plan that would allow a
coronavirus relief bill to muscle through in the coming weeks
without Republican support.

"We now have a situation where the Democrats do not need
Republican approval in order to move ahead with the full $1.9
trillion stimulus package," said Thomas Hayes, managing member
at Great Hill Capital LLC in New York.

Stocks gained even after news that South Africa had halted
the rollout of AstraZeneca's vaccine after a study showed it
gave only limited protection against the country's more
contagious variant of the coronavirus.

The Dow Jones Industrial Average rose 131.57 points,
or 0.42%, to 31,279.81, the S&P 500 gained 10.62 points,
or 0.27%, to 3,897.45 and the Nasdaq Composite added
49.03 points, or 0.35%, to 13,905.32.

The pan-European STOXX 600 index rose 0.42% and
MSCI's gauge of stocks across the globe gained
0.47%. The MSCI index hit its ninth record high of 2021
overnight.

Brent oil surpassed $60 a barrel. Brent was up 68
cents, or 1.2%, at $60.02, while U.S. West Texas Intermediate
rose 68 cents, or 1.2%, to $57.53.

The dollar was flat to slightly lower in choppy trading,
holding its ground against a basket of major currencies as
investors continued to price in a faster U.S. recovery than in
most countries.

The dollar index rose 0.057%, with the euro
down 0.03% to $1.2038.

Benchmark 10-year Treasury notes last rose 5/32
in price to yield 1.155%, from 1.17% late on Friday.

(Additional reporting by Marc Jones in London and Swati Pandey
in Sydney; Editing by Larry King and Dan Grebler)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.